deuteporfin (DTBF) / Shanghai Fudan-Zhangjiang - LARVOL DELTA

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma (clinicaltrials.gov) - P2; N=7; Terminated; Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.; N=50 ➔ 7; Trial completion date: May 2019 ➔ Dec 2018; Recruiting ➔ Terminated; Business Decision

Clinical • Enrollment change • Trial completion date • Trial termination